Anavex Life Sciences
Yahoo Finance • 8 days ago
Anavex Life Sciences receives Nasdaq delinquency notice
* Anavex Life Sciences (AVXL [https://seekingalpha.com/symbol/AVXL]) said on Friday it received an expected delinquency notification letter from the Nasdaq on May 20, 2026, after failing to timely file its Form 10-Q for the quarter ended... Full story
Yahoo Finance • 24 days ago
Anavex slips after CEO transition
[Ceo sign on wooden cubes. Ceo Concept.close up of wooden cubes,Business Concept.3D rendering on yellow background.] fengdr/iStock via Getty Images Shares of Anavex Life Sciences (AVXL [https://seekingalpha.com/symbol/AVXL]) fell ~3% on W... Full story
Yahoo Finance • last month
Exploring Three High Growth Tech Stocks In The US Market
In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings expected to grow by 16% per annum in the coming years. In this context of robust growth expectations, identifying h... Full story
Yahoo Finance • 2 months ago
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic dysfunction across neurodevelopmental and neurodegenerative condition... Full story
Yahoo Finance • 2 months ago
Anavex Life Sciences Provides Comprehensive Regulatory Update
Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral blarcamesine in early Alzheimer’s disease Additional data submitted to the U.S. FDA with the objective to discuss potential pathways toward... Full story
Yahoo Finance • 2 months ago
Anavex drops after pulling EU marketing application for Alzheimer’s therapy
[An arrow pointing downwards on top of a pile of US dollar bills.] Anavex Life Sciences (AVXL [https://seekingalpha.com/symbol/AVXL]) lost ~18% in the premarket on Wednesday after the company announced that it withdrew the marketing autho... Full story
Yahoo Finance • 3 months ago
3 Promising Penny Stocks With At Least $200M Market Cap
As the United States stock market kicks off February with a strong start, major indexes like the Dow Jones and S&P 500 have shown impressive gains. In this context of optimism, penny stocks—often overlooked due to their smaller size or you... Full story
Yahoo Finance • 4 months ago
Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson'... Full story
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at... Full story
Yahoo Finance • 5 months ago
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's
[Alzheimers Concept Horizontal] travellinglight * Anavex Life Sciences (AVXL [https://seekingalpha.com/symbol/AVXL]) has formally asked the European Medicines Agency to re-examine its opinion [https://seekingalpha.com/news/4531047-ema-r... Full story
Yahoo Finance • 5 months ago
Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion
NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson'... Full story
Yahoo Finance • 5 months ago
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
LOS ANGELES, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life Sciences Corp. (“Anavex” or “the Company”)... Full story
Yahoo Finance • 6 months ago
SA Quant ranks Goldman's small-cap stocks with largest short interest
[Multi screen fintech investing gold and silver trading on digital screen corporating with AI artificial intelligence financial business data on commodity investment] primeimages Goldman Sachs analysts last week identified 50 small-cap st... Full story
Yahoo Finance • 6 months ago
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson'... Full story
Yahoo Finance • 6 months ago
Anavex Life Sciences GAAP EPS of -$0.11 beats by $0.04
* Anavex Life Sciences press release [https://seekingalpha.com/pr/20319558-anavex-life-sciences-reports-fiscal-2025-fourth-quarter-financial-results-and-provides] (AVXL [https://seekingalpha.com/symbol/AVXL]): Q4 GAAP EPS of -$0.11 beats... Full story
Yahoo Finance • 6 months ago
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
Company to host a webcasttoday at 8:30 a.m. Eastern Time NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing... Full story
Yahoo Finance • 6 months ago
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * Alibaba Group Holding Limited (BABA [https://seekingalpha.com/symbol/BABA]) * NIO (NIO [https://seekingalpha.com/symbol/NIO]) * Best Buy Co. (BBY [https://seekingalpha.co... Full story
Yahoo Finance • 6 months ago
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson'... Full story
Yahoo Finance • 6 months ago
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson'... Full story
Yahoo Finance • 6 months ago
Anavex tumbles as Alzheimer’s therapy faces EU rejection
[Alzheimers Concept Horizontal] travellinglight/iStock via Getty Images Anavex Life Sciences (AVXL [https://seekingalpha.com/symbol/AVXL]) lost ~47% in the premarket on Friday after a group of experts appointed by the EU drug regulator, t... Full story